We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Imaging Agent Could Help Measure Effectiveness of Breast Cancer Therapy Earlier

News   Feb 12, 2019 | Original story from the Society of Nuclear Medicine and Molecular Imaging

 
Imaging Agent Could Help Measure Effectiveness of Breast Cancer Therapy Earlier

Representative coronal 18F-FFNP PET/CT images of MDA-MB-231 (red arrow), 231 PR-A (white arrows), and 231 PR-B (yellow arrow) tumor xenografts (19 d after implantation) from 12 mice imaged 1 h after injection with 10 MBq (270 μCi) of 18F-FFNP. Physiologic uptake from hepatobiliary clearance is also visualized. Credit: K Salem et al., University of Wisconsin School of Medicine and Public Health, Madison, WI

 
 
 

RELATED ARTICLES

Lithium Reverses Radiation Damage After Brain Tumor Treatment

News

Research in mice has shown that the drug lithium can be used to reverse radiation damage from the treatment of brain tumors.

READ MORE

New Technique Improves Imaging of Cells

News

Researchers have developed a new technique for fluorescence lifetime imaging of tissue and cells, which could lay the groundwork for use in a clinical setting.

READ MORE

ELeCt-ing a New Contender for Chemo Delivery

News

A new technique called ELeCt (erythrocyte-leveraged chemotherapy) aims to resolve the problems that come with using the age-old "Trojan Horse trick" to smuggle drug-loaded nanoparticles into cancerous lung tissue.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE